- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00788645
The Use of a Forecasting System for Predicting Exacerbations of COPD
November 30, 2010 updated by: AstraZeneca
The Use of a Forecasting System for Predicting Exacerbations of COPD: Effect on Symptoms and Hospitalisation and Relevance of Viral Infections
People with Chronic Obstructive Pulmonary Disease (COPD) often have periods during the year when their symptoms become worse.
These are often due to an infection and are called "exacerbations" by doctors.
Exacerbations are more common in the winter and also seem to be related to particular types of weather.
As well as forecasting the weather the UK Met Office has developed a system to try to predict when exacerbations are likely to occur.
The main purpose of this research study is to find out whether the Met Office forecasting service can predict when exacerbations are more likely to occur and whether the advice given during the predicted higher risk periods leads to fewer patients having an exacerbation or if it reduces the impact of the exacerbation.
The study will also assess if there is a link between viral or bacterial infection and breathing problems that occur during the study period.
The study will also collect information about possible causes of the breathing problems and what happens to the person afterwards.
The results of this study will help us learn more about breathing problems which may lead to new research studies that would aim to improve the care of people with COPD.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
98
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Exeter, United Kingdom
- Research Site
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Current or former smokers with a diagnosis of COPD
- Having impaired lung function as measured by spirometry
Exclusion Criteria:
- History of asthma or nasal symptoms caused by hayfever
- No telephone
- Inability to record symptoms in an electronic diary (PDA)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Forecast
COPD patients receiving advice and poor weather warning
|
Information leaflets on COPD and thermometers to monitor the ambient temperature in the bedroom and living room
Interactive automated telephone service to contact patients prior to anticipated periods of poor weather
|
|
Experimental: No Forecast
COPD patients receiving advice and poor weather warning
|
Information leaflets on COPD and thermometers to monitor the ambient temperature in the bedroom and living room
|
|
No Intervention: Control
Age matched non - COPD subjects
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The incidence and frequency of COPD exacerbations in each of the intervention groups
Time Frame: December 2008 to March 2009 inclusive
|
December 2008 to March 2009 inclusive
|
|
Electronic diary symptoms using the EXACT instrument
Time Frame: Daily recording
|
Daily recording
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Medication usage and hospital admissions
Time Frame: Acutely
|
Acutely
|
|
Changes in the St Georges Respiratory questionaire
Time Frame: Start and end of study period
|
Start and end of study period
|
|
Severity and duration of exacerbations assessed using the EXACT instrument
Time Frame: Daily recording
|
Daily recording
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David Halpin, MD, Royal Devon and Exeter Hospital, Exeter, Devon, UK
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2008
Primary Completion (Actual)
March 1, 2009
Study Completion (Actual)
March 1, 2009
Study Registration Dates
First Submitted
November 10, 2008
First Submitted That Met QC Criteria
November 10, 2008
First Posted (Estimate)
November 11, 2008
Study Record Updates
Last Update Posted (Estimate)
December 2, 2010
Last Update Submitted That Met QC Criteria
November 30, 2010
Last Verified
November 1, 2010
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- D6256M00017
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease (COPD)
-
Ryme Medical, Inc.Not yet recruitingCOPD | Lung Disease, Chronic Obstructive | COPD Patients | COPD Acute Exacerbation | COPD (Chronic Obstructive Pulmonary Disease) | Lung Disease Airways | COPD Exacerbations
-
University College, LondonUniversity of Cambridge; National Institute for Health Research, United Kingdom and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Virginia Commonwealth UniversityFisher and Paykel HealthcareCompletedChronic Obstructive Pulmonary Disease(COPD)United States
-
Morair Medtech, LLCRecruitingEmphysema | COPD | Emphysema or COPD | COPD (Chronic Obstructive Pulmonary Disease) | Emphysema, PulmonaryAustria, Germany, Netherlands
-
Reham Mohammed ElmorshedyCompletedChronic Obstructive Pulmonary Disease(COPD)Egypt
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD).United Kingdom
-
Medtronic BRCUnknownCOPD | COPD Exacerbation
-
Beaumont HospitalAerogenCompletedChronic Obstructive Pulmonary Disease | COPD | COPD Exacerbation | Copd Exacerbation AcuteIreland
-
Chiesi Farmaceutici S.p.A.CompletedModerate to Severe Chronic Obstructive Pulmonary Disease (COPD)Bulgaria, Germany, Hungary, Poland, Russian Federation, United Kingdom
-
Barron Associates, Inc.National Heart, Lung, and Blood Institute (NHLBI); University of VirginiaNot yet recruitingCOPD | COPD - Chronic Obstructive Pulmonary DiseaseUnited States
Clinical Trials on COPD self care advice
-
Fondazione Policlinico Universitario Agostino Gemelli...Active, not recruiting
-
Karolinska InstitutetSwedish Council for Working Life and Social ResearchCompleted
-
The University of Texas Health Science Center at...National Heart, Lung, and Blood Institute (NHLBI); University of Alabama at... and other collaboratorsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
National Institute of Diabetes and Digestive and...Completed
-
University College, LondonJohns Hopkins University; Makerere University; Universidad Peruana Cayetano Heredia and other collaboratorsUnknownChronic Obstructive Pulmonary DiseasePeru, Nepal, Uganda
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Institut Catala de SalutUnknownChronic Obstructive Pulmonary DiseaseSpain
-
University of California, San FranciscoNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCOPD (Chronic Obstructive Pulmonary Disease)United States
-
China-Japan Friendship HospitalRecruitingChronic Obstructive Pulmonary DiseaseChina
-
Icahn School of Medicine at Mount SinaiNational Heart, Lung, and Blood Institute (NHLBI); Baystate Medical Center; VNS...RecruitingChronic Obstructive Pulmonary DiseaseUnited States
-
Landeskrankenanstalten-BetriebsgesellschaftEuropean CommissionCompletedPulmonary Disease, Chronic Obstructive (COPD)Austria